Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Oncogene ; 35(17): 2197-207, 2016 04 28.
Artigo em Inglês | MEDLINE | ID: mdl-26257057

RESUMO

Enhanced sensitivity to Wnts is an emerging hallmark of a subset of cancers, defined in part by mutations regulating the abundance of their receptors. Whether these mutations identify a clinical opportunity is an important question. Inhibition of Wnt secretion by blocking an essential post-translational modification, palmitoleation, provides a useful therapeutic intervention. We developed a novel potent, orally available PORCN inhibitor, ETC-1922159 (henceforth called ETC-159) that blocks the secretion and activity of all Wnts. ETC-159 is remarkably effective in treating RSPO-translocation bearing colorectal cancer (CRC) patient-derived xenografts. This is the first example of effective targeted therapy for this subset of CRC. Consistent with a central role of Wnt signaling in regulation of gene expression, inhibition of PORCN in RSPO3-translocated cancers causes a marked remodeling of the transcriptome, with loss of cell cycle, stem cell and proliferation genes, and an increase in differentiation markers. Inhibition of Wnt signaling by PORCN inhibition holds promise as differentiation therapy in genetically defined human cancers.


Assuntos
Neoplasias Colorretais/tratamento farmacológico , Neoplasias Colorretais/genética , Compostos Heterocíclicos de 4 ou mais Anéis/administração & dosagem , Proteínas de Membrana/genética , Proteínas Wnt/genética , Aciltransferases , Animais , Linhagem Celular Tumoral , Neoplasias Colorretais/patologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Proteínas de Membrana/antagonistas & inibidores , Camundongos , Processamento de Proteína Pós-Traducional , Células-Tronco/efeitos dos fármacos , Proteínas Wnt/antagonistas & inibidores , Via de Sinalização Wnt/efeitos dos fármacos , Ensaios Antitumorais Modelo de Xenoenxerto
2.
Singapore Med J ; 52(8): 586-91, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21879217

RESUMO

Bystander cardiopulmonary resuscitation (CPR) is important for survival from out-of-hospital cardiac arrest (OHCA). However, recent research indicates that the quality of CPR is an important and often overlooked factor affecting survival. Individual factors, training, awareness, technique and rescuer fatigue may influence the quality of CPR. Quality components of CPR include rate, ratio, depth and ventilation-compression ratio. The new 2010 CPR guidelines advocate a ratio of compressions to ventilations of 30:2, with a rate of at least 100 compressions per minute. Depth of compression should be at least 5 cm. Rescuers should allow complete recoil of the chest. Locally, limited information is available regarding the quality of CPR being performed for OHCA. Strategies to improve the quality of CPR include research, training, education as well as incorporating appropriate technologies that measure and feedback the quality of CPR. These technologies are at the heart of recent advances, as they now make it feasible to provide routine feedback to rescuers providing CPR, through the integration of feedback devices into training equipment, defibrillators and standalone CPR assist devices.


Assuntos
Reanimação Cardiopulmonar/métodos , Reanimação Cardiopulmonar/normas , Parada Cardíaca Extra-Hospitalar/terapia , Guias de Prática Clínica como Assunto , Serviços de Saúde Comunitária/métodos , Desfibriladores/normas , Serviços Médicos de Emergência/métodos , Serviços Médicos de Emergência/normas , Humanos , Qualidade da Assistência à Saúde , Singapura
3.
Singapore Med J ; 52(8): 631-3, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21879225

RESUMO

There is a need to establish a National Sudden Cardiac Arrest registry that would track the performance and outcomes of out-of-hospital (OHCA) and in-hospital cardiac arrests (IHCA) in the country. An effective strategy to improve survival from sudden cardiac arrest in Singapore requires a multi-pronged effort targeting the community, Emergency Medical Services (EMS) and the hospitals. The establishment of such a registry is important, as it would enable the tracking of trends and effectiveness of subsequent interventions related to our national strategy for management of both OHCA and IHCA. The quality improvement process of measurement-benchmarking-feedback/change is well established. A key part of this process is data collection. A cardiac arrest registry can be a key tool for quality improvement and serves as an important foundation on which to implement and track planned improvements to cardiac arrest management both in and out of hospital. It would also aid in planning for deployment of resources, interventions and ongoing efforts to improve Singapore's EMS.


Assuntos
Parada Cardíaca , Vigilância da População/métodos , Sistema de Registros , American Heart Association , Centers for Disease Control and Prevention, U.S. , Serviços Médicos de Emergência/métodos , Serviços Médicos de Emergência/normas , Parada Cardíaca/epidemiologia , Parada Cardíaca/terapia , Humanos , Melhoria de Qualidade , Indicadores de Qualidade em Assistência à Saúde , Singapura/epidemiologia , Estados Unidos
4.
Singapore Med J ; 51(10): 831-4; quiz 835, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21103821

RESUMO

The Singapore Armed Forces (SAF) Medical Corps and the Ministry of Health (MOH) have published clinical practice guidelines on Management of Heat Injury to provide doctors and patients in Singapore with evidence-based guidance on the prevention and clinical management of exertional heat injuries. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the SAF Medical Corps-MOH clinical practice guidelines on Management of Heat Injury, for the information of readers of the Singapore Medical Journal. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/mohcorp/publications.aspx?id=25178. The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.


Assuntos
Exaustão por Calor/diagnóstico , Exaustão por Calor/prevenção & controle , Golpe de Calor/diagnóstico , Golpe de Calor/prevenção & controle , Temperatura Alta , Temperatura Corporal , Medicina Baseada em Evidências , Humanos , Militares , Guias de Prática Clínica como Assunto , Singapura
5.
Cell Mol Life Sci ; 62(2): 227-38, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15666094

RESUMO

Many have hypothesized that cell death in Parkinson's disease is via apoptosis and, specifically, by the mitochondrial-mediated apoptotic pathway. We tested this hypothesis using a mouse dopaminergic cell line of mesencephalic origin, MN9D, challenged with the Parkinsonism-causing neurotoxin MPP+ (1-methyl-4-phenylpyridinium ion). Apoptosis was the main mode of cell death when the cells were subjected to MPP+ treatment under serum-free conditions for 24 h. Caspase-3 and caspase-9, however, were not activated, thus indicating the existence of alternate or compensatory cell death pathway(s) in dopaminergic neuronal cells. Using caspase inhibitors, we demonstrated that these pathways involve caspase-2, -8, -6 and -7. A time-course study indicated that activation of caspase-2 and -8 occurred upstream of caspase-6 and caspase-7. Upon MPP+ challenge, the apoptosis-inducing factor was translocated from the mitochondria into the MN9D cytosol and nucleus. These results suggest the existence of alternative apoptotic pathways in dopaminergic neurons.


Assuntos
Apoptose , Caspases/metabolismo , Dopamina/metabolismo , Neurônios/citologia , Neurônios/enzimologia , 1-Metil-4-fenilpiridínio/toxicidade , Animais , Fator de Indução de Apoptose , Caspase 2 , Caspase 3 , Caspase 6 , Caspase 7 , Caspase 8 , Caspase 9 , Linhagem Celular , Citocromos c/biossíntese , Ativação Enzimática , Flavoproteínas/metabolismo , Proteínas de Membrana/metabolismo , Camundongos , Mitocôndrias/metabolismo , Neurônios/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA